Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Grothey

Showing results (71-80 of 303) with videos related to

Pageof 31
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
How to incorporate a chemo-free interval into the management of metastatic colorectal cancer: discussionAxel Grothey, John L Marshall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
New lessons from "old" chemotherapy in colorectal cancerAxel Grothey, Daniel J Sargent
The Oncologist|August 28, 2012
Establishing a standard of care for small bowel adenocarcinomas: challenges and lessons learnedThorvardur R Halfdanarson, Axel Grothey
Expert Review of Anticancer Therapy|July 24, 2004
Developments in combination chemotherapy for colorectal cancerMatthew P Goetz, Axel Grothey
Oncology (Williston Park, N.Y.)|June 1, 2007
Optimizing palliative treatment of metastatic colorectal cancer in the era of biologic therapyAxel Grothey, John L Marshall
Lancet (London, England)|April 12, 2015
When less is more: maintenance therapy in colorectal cancerJoleen M Hubbard, Axel Grothey
Clinical Colorectal Cancer|October 10, 2006
Do all patients with metastatic colorectal cancer need chemotherapy until disease progression?Tara Beers Gibson, Axel Grothey
Drugs|May 14, 2018
Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor PatientsPashtoon Murtaza Kasi, Axel Grothey
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal CancerAxel Grothey, Alan P Venook
Clinical Colorectal Cancer|December 13, 2005
Enhancing oxaliplatin-based regimens in colorectal cancer by inhibiting the epidermal growth factor receptor pathwayGeorge P Kim, Axel Grothey
Pageof 31

Showing results (71-80 of 303) with videos related to

Sort By:
Pageof 31
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
How to incorporate a chemo-free interval into the management of metastatic colorectal cancer: discussionAxel Grothey, John L Marshall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
New lessons from "old" chemotherapy in colorectal cancerAxel Grothey, Daniel J Sargent
The Oncologist|August 28, 2012
Establishing a standard of care for small bowel adenocarcinomas: challenges and lessons learnedThorvardur R Halfdanarson, Axel Grothey
Expert Review of Anticancer Therapy|July 24, 2004
Developments in combination chemotherapy for colorectal cancerMatthew P Goetz, Axel Grothey
Oncology (Williston Park, N.Y.)|June 1, 2007
Optimizing palliative treatment of metastatic colorectal cancer in the era of biologic therapyAxel Grothey, John L Marshall
Lancet (London, England)|April 12, 2015
When less is more: maintenance therapy in colorectal cancerJoleen M Hubbard, Axel Grothey
Clinical Colorectal Cancer|October 10, 2006
Do all patients with metastatic colorectal cancer need chemotherapy until disease progression?Tara Beers Gibson, Axel Grothey
Drugs|May 14, 2018
Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor PatientsPashtoon Murtaza Kasi, Axel Grothey
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal CancerAxel Grothey, Alan P Venook
Clinical Colorectal Cancer|December 13, 2005
Enhancing oxaliplatin-based regimens in colorectal cancer by inhibiting the epidermal growth factor receptor pathwayGeorge P Kim, Axel Grothey
Pageof 31